Mourad Dellagi

发表

Intravenous ketamine is a risk factor for jaundice in Covid-19 patients

V. Frochot, E. Letavernier, J. Correas, 2021, Journal of Hepatology.

Analysis of the impact of the SARS-CoV-2 infection on the pediatric population hospitalized during the pandemic in the Greater Paris University Hospitals

N. Beeker, H. Chappuy, M. Semeraro, 2023, Frontiers in Pediatrics.

Reply to: “Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered”

V. Frochot, E. Letavernier, J. Correas, 2021, Journal of Hepatology.

Disease burden of Barrett's esophagus across the Paris metropolitan area.

N. Beeker, Mourad Dellagi, Mathis Collier, 2024, Clinics and research in hepatology and gastroenterology.